5.7 comparative bioavailability and safety of a novel trimodal dexmethylphenidate tablet in adhd patients

The primary objectives of this study were to compare the bioavailability of 2 dexmethylphenidate (d-MPH) formulations, CTx-1301 (trimodal tablet) vs Focalin XR (biphasic capsule), and to demonstrate the dose proportionality of the CTx-1301. The secondary objectives were to characterize the pharmacokinetics and evaluate the safety.
Source: Journal of the American Academy of Child and Adolescent Psychiatry - Category: Psychiatry Authors: Source Type: research